Showing 21 - 40 results of 264 for search '"angiogenesis inhibitor"', query time: 0.12s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24

    Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). by Hatanaka, H, Oshika, Y, Abe, Y, Yoshida, Y, Hashimoto, T, Handa, A, Kijima, H, Yamazaki, H, Inoue, H, Ueyama, Y, Nakamura, M

    Published 2000
    “…Brain-specific angiogenesis inhibitor 1 (BAI1) is a novel angioinhibitory factor. …”
    Journal article
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29

    The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis. by Sumariwalla, P, Cao, Y, Wu, H, Feldmann, M, Paleolog, E

    Published 2002
    “…Protease-activated kringles 1-5 (K1-5) is an angiogenesis inhibitor related to angiostatin. In common with angiostatin, K1-5 contains the first four kringle domains of plasminogen, but also encompasses the kringle 5 domain, which confers enhanced antiangiogenic activity when compared with angiostatin. …”
    Journal article
  10. 30

    Automated in vivo compound screening with zebrafish and the discovery and validation of PD 81,723 as a novel angiogenesis inhibitor by Antonio N. Mauro, Paul J. Turgeon, Sahil Gupta, Koroboshka Brand-Arzamendi, Hao Chen, Jeanie H. Malone, Robin Ng, Kevin Ho, Michelle Dubinsky, Caterina Di Ciano-Oliveira, Christopher Spring, Pamela Plant, Howard Leong-Poi, John C. Marshall, Philip A. Marsden, Kim A. Connelly, Krishna K. Singh

    Published 2022-08-01
    “…This manuscript presents the results of a screen of the National Institutes of Health Clinical Collections Libraries I & II (NIHCCLI&II) for novel angiogenesis inhibitors. The 727 compounds of the NIHCCLI&II library were screened with a high-throughput drug discovery platform (HTP) developed previously with angiogenesis-specific protocols utilizing zebrafish. …”
    Get full text
    Article
  11. 31

    The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration by N.S. Zhayvoronok, O.V. Kolenko, L.P. Danilova, E.L. Sorokin

    Published 2022-11-01
    “…The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration. …”
    Get full text
    Article
  12. 32
  13. 33
  14. 34
  15. 35
  16. 36
  17. 37

    Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study by Zengjun Liu, Jing Xu, Mengyao Liu, Wenyu Hu, Ni Xu, Dongyuan Zhu

    Published 2023-02-01
    “…Abstract Angiogenesis inhibitors (AIs) and immune checkpoint inhibitors (ICIs) are new treatment options for advanced soft tissue sarcoma (STS) patients. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40